The human term placenta collected after birth is a waste tissue that harbors large quantities of fetal and maternal stem cells. So far, separation between fetal and maternal cells has proven tedious and unreliable. We here review recent findings regarding the prospective isolation of large quantities of fetal endothelial progenitors as well as pure preparations of fetal or maternal mesenchymal stromal cells from the same placenta. This is conducted by using a unique cell sorting strategy that does not require any precise dissection of the placenta. Furthermore, we also review the cell identification of endothelial progenitors and mesenchymal stem cells and the establishment of better guidelines in disseminating populations and their functio...
A need to identify a stem cell source for human endothelial colony forming cells (ECFCs) and mesench...
Endothelial progenitor cells (EPC) have been proposed as a cell population with de novo vessel forma...
Regenerative medicine based on cell therapy and tissue engineering methodologies is a newly emerging...
The human term placenta collected after birth is a waste tissue that harbors large quantities of fet...
Since the isolation of fetal stem cell populations from perinatal tissues, such as umbilical cord bl...
Mounting evidence suggests that the human term placenta could be a source of stem/progenitor cells w...
Mesenchymal stem/stromal cells (MSC) are promising candidates for use in cell-based therapies. In mo...
The term placenta is a highly vascularized tissue and is usually discarded upon birth. Our objective...
Human placenta is rich in mesenchymal stem/stromal cells (MSC), with their origin widely presumed fe...
The placenta is an abundant source of mesenchymal stem/stromal cells (MSC). Although presumed of tra...
Placental tissue draws great interest as a source of cells for regenerative medicine because of the ...
Placental tissue draws great interest as a source of cells for regenerative medicine because of the ...
Placental tissue draws great interest as a source of cells for regenerative medicine because of the ...
Purpose: This study was aimed at determining whether fetal tissue constructs can be engineered from ...
[[abstract]]Current sources of stem cells include embryonic stem cells (ESCs) and adult stem cells (...
A need to identify a stem cell source for human endothelial colony forming cells (ECFCs) and mesench...
Endothelial progenitor cells (EPC) have been proposed as a cell population with de novo vessel forma...
Regenerative medicine based on cell therapy and tissue engineering methodologies is a newly emerging...
The human term placenta collected after birth is a waste tissue that harbors large quantities of fet...
Since the isolation of fetal stem cell populations from perinatal tissues, such as umbilical cord bl...
Mounting evidence suggests that the human term placenta could be a source of stem/progenitor cells w...
Mesenchymal stem/stromal cells (MSC) are promising candidates for use in cell-based therapies. In mo...
The term placenta is a highly vascularized tissue and is usually discarded upon birth. Our objective...
Human placenta is rich in mesenchymal stem/stromal cells (MSC), with their origin widely presumed fe...
The placenta is an abundant source of mesenchymal stem/stromal cells (MSC). Although presumed of tra...
Placental tissue draws great interest as a source of cells for regenerative medicine because of the ...
Placental tissue draws great interest as a source of cells for regenerative medicine because of the ...
Placental tissue draws great interest as a source of cells for regenerative medicine because of the ...
Purpose: This study was aimed at determining whether fetal tissue constructs can be engineered from ...
[[abstract]]Current sources of stem cells include embryonic stem cells (ESCs) and adult stem cells (...
A need to identify a stem cell source for human endothelial colony forming cells (ECFCs) and mesench...
Endothelial progenitor cells (EPC) have been proposed as a cell population with de novo vessel forma...
Regenerative medicine based on cell therapy and tissue engineering methodologies is a newly emerging...